CD4 and inflammatory bowel disease: It has been reported that JKAP regulates the functions of T cells, for instance, JKAP can inhibit the CD4+ T cell activation and differentiation to Th1 and Th17 cells in peripheral blood mononuclear cell (PBMC) collected from patients with active inflammatory bowel disease (IBD) [14].